Abstract
India currently has the world's second-largest population along with a fast-growing economy and significant economic disparity. It also continues to experience a high rate of infectious disease and increasingly higher rates of chronic diseases. However, India cannot afford to import expensive technologies and therapeutics nor can it, as an emerging economy, emulate the health-delivery systems of the developed world. Instead, to address these challenges it is looking to biotechnology-based innovation in the field of genomics. The Indian Genome Variation (IGV) consortium, a government-funded collaborative network among seven local institutions, is a reflection of these efforts. The IGV has recently developed the first large-scale database of genomic diversity in the Indian population that will facilitate research on disease predisposition, adverse drug reactions and population migration.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Boutayeb, A. The double burden of communicable and non-communicable diseases in developing countries. Trans. R. Soc. Trop. Med. Hyg. 100, 191–199 (2006).
Indian Genome Variation Consortium. Genetic landscape of the people of India: a canvas for disease gene exploration. J. Genet. 87, 3–20 (2008).
Indian Genome Variation Consortium. The Indian Genome Variation database (IGVdb): a project overview. Hum. Genet. 118, 1–11 (2005).
Séguin, B. & Hardy, B, Singer, P. A. & Daar, A. S. Genomic medicine and developing countries: creating a room of their own. Nature Rev. Genet. 9, 487–493 (2008).
Séguin, B., Hardy, B., Singer, P. A. & Daar, A. S. Human genomic variation initiatives in emerging economies and developing countries. Nature Rev. Genet. 9 (Suppl), S3–S4 (2008).
Nundy, S. & Gulhati, C. M. A new colonialism? — Conducting clinical trials in India. N. Engl. J. Med. 352, 1633–1636 (2005).
Maiti, R. & M, R. Clinical trials in India. Pharmacol. Res. 56, 1–10 (2007).
Singh, S. India Bullish on Global Clinical Trial Business Opportunity. Science and Marketplace [online], (2006).
Thiers, F., Sinskey, A. & Berndt, E. Trends in the globalization of clinical trials. Nature Rev. Drug Discov. 7, 13–14 (2008).
Frew, S. E. et al. India's health biotech sector at a crossroads. Nature Biotechnol. 25, 403–417 (2007).
Patwardhan, B. Ayugenomics: integration for customized medicine. Indian J. Nat. Products 19, 16–23 (2003).
Patwardhan, B., Vaidya, A. & Chorghade, M. Ayurveda and natural product drug discovery. Current Sci. 86, 789–799 (2004).
Indo-Asian News Service. Indian biotech sector crosses $2 billion in FY 2007. Twocircles.net [online], (2007).
Jayaraman, K. S. Database targets Parsi genes. Nature 446, 475 (2007).
Becerril, A. Aprueba el Senado sanciones a quienes trasladen tejido humano fuera de México. La Journada [online], (2008) (in Spanish).
Prathapan, K. et al. Death sentence on taxonomy in India. Curr. Sci. 94, 170–171 (2008).
Mudur, G. India invests heavily in genomics research. BMJ 322, 576 (2001).
Stein, L. Congress Passes Bill Barring Genetic Discrimination. Scientific American [online], (2008).
Kukreti, R. et al. Beta(2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics. Pharmacogenomics 6, 399–410 (2005).
Bhatnagar, P., Guleria, R. & Kukreti, R. Variable therapeutic response in asthma: a genetic perspective. Personalized Medicine 3, 61–78 (2006).
Séguin, B., Hardy, B., Singer, P. A. & Daar, A. S. Genomics, public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN). Nature Rev. Genet. 9 (Suppl), S5–S9 (2008).
Thorsteinsdottir, H., Quach, U., Daar, A. S. & Singer, P. A. Conclusions: promoting biotechnology innovation in developing countries. Nature Biotechnol. 22 (Suppl), DC48–DC52 (2004).
Frew, S. E., Sammut, S. M., Siu, W. W., Daar, A. S. & Singer, P. A. The role of the domestic private sector in developing countries for addressing local health needs. Int. J. Biotechnology 8, 91–102 (2006).
Holm, S. in The Power of Pills: Social, Ethical and Legal Issues in Drug Development, Marketing and Pricing (eds Cohen, J. C., Illingworth, P. & Schuklenk, U.) 98–109 (Pluto Press, Ann Arbor, Michigan, 2006).
Prahalad, C. K. & Hart, S. L. The Fortune at the Bottom of the Pyramid. Strategy and Business Magazine. [online], (2002).
Hardy, B., Séguin, B., Ramesar, R., Singer, P. A. & Daar, A. S. South Africa: from species cradle to genomic applications. Nature Rev. Genet. 9 (Suppl), S19–S23 (2008).
Séguin, B., Hardy, B., Singer, P. A. & Daar, A. S. Universal health care, genomic medicine and Thailand: Investing in today and tomorrow. Nature Rev. Genet. 9 (Suppl), S14–S19 (2008).
Acknowledgements
This project was funded by Genome Canada through the Ontario Genomics Institute. The Indian Council of Medical Research provided in kind co-funding for this research. The McLaughlin–Rotman Centre for Global Health, Program on Life Sciences, Ethics and Policy is primarily supported by Genome Canada through the Ontario Genomics Institute, the Ontario Research Fund, and the Bill and Melinda Gates Foundation. Other matching partners are listed atThe McLaughlin–Rotman Centre for Global Health web site. A.S.D. and P.A.S. are supported by the McLaughlin Centre for Molecular Medicine. P.A.S. is supported by a Canadian Institutes of Health Research Distinguished Investigator award. The IGV project was supported by SCIR, India.
Author information
Authors and Affiliations
Corresponding author
Related links
Related links
FURTHER INFORMATION
McLaughlin–Rotman Centre for Global Health
Africa Genome Education Institute
Census of India Rural–Urban Distribution
Ethical Guidelines for Biomedical Research on Human Participants
Guidelines for Exchange of Human Biological Material for Biomedical Research Purposes
Human Genetics and Genome Analysis
India Country Overview 2007, World Bank web site
National Biotechnology Development Strategy
National Institute of Genomic Medicine (INMEGEN), Mexico
New Millennium Indian Technology Leadership Initiative
Rights and permissions
About this article
Cite this article
Hardy, BJ., Séguin, B., Singer, P. et al. From diversity to delivery: the case of the Indian Genome Variation initiative. Nat Rev Genet 9 (Suppl 1), S9–S14 (2008). https://doi.org/10.1038/nrg2440
Issue Date:
DOI: https://doi.org/10.1038/nrg2440
This article is cited by
-
Whole genome analysis of a Vietnamese trio
Journal of Biosciences (2015)
-
The next steps for genomic medicine: challenges and opportunities for the developing world
Nature Reviews Genetics (2008)